ALBION FINANCIAL GROUP /UT - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 34 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALBION FINANCIAL GROUP /UT ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$4,000
-20.0%
12,0000.0%0.00%0.0%
Q4 2019$5,000
+25.0%
12,0000.0%0.00%0.0%
Q3 2019$4,000
+33.3%
12,0000.0%0.00%
Q2 2019$3,000
-76.9%
12,0000.0%0.00%
-100.0%
Q1 2019$13,000
-38.1%
12,0000.0%0.00%
-33.3%
Q4 2018$21,00012,0000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders